Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Revance Therapeutics Inc. (RVNC)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
RVNC Insider Trading Transactions for Revance Therapeutics  Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-03-15
Sale
2019-03-19
9:01 pm
Revance Therapeutics Inc. RVNC Browne L Daniel
CEO
11,613 $15.51 $180,068 165,687
(Indirect
Direct)
View
2019-03-15
Sale
2019-03-19
8:58 pm
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
498 $15.48 $7,709 6,898
(Direct)
View
2019-02-15
Sale
2019-02-20
9:31 pm
Revance Therapeutics Inc. RVNC Browne L Daniel
CEO
5,446 $17.68 $96,285 174,389
(Indirect
Direct)
View
2019-01-22
Sale
2019-01-23
9:38 pm
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
625 $17.77 $11,106 6,875
(Direct)
View
2019-01-03
Sale
2019-01-04
9:33 pm
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
375 $19.48 $7,305 4,000
(Direct)
View
2018-11-20
Sale
2018-11-21
6:30 pm
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
491 $20.66 $10,144 4,000
(Direct)
View
2018-11-09
Sale
2018-11-09
8:59 pm
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
2,188 $23.72 $51,899 7,500
(Direct)
View
2018-07-06
Sale
2018-07-06
9:17 pm
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Financial Officer
393 $28.35 $11,142 4,750
(Direct)
View
2018-05-22
Sale
2018-05-24
7:24 pm
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
2,874 $30.25 $86,924 65,497
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-05-09
Option Award
2019-05-10
9:11 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Vickers Philip J.
Director
4,500 $0 13,650
(Direct)
View
2019-05-09
Option Award
2019-05-10
9:11 pm
N/A
2029-05-08
Revance Therapeutics Inc. RVNC Vickers Philip J.
Director
9,000 $12.82 13,650
(Direct)
View
2019-05-09
Option Award
2019-05-10
9:09 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Russell Angus C.
Director
4,500 $0 10,500
(Direct)
View
2019-05-09
Option Award
2019-05-10
9:09 pm
N/A
2029-05-08
Revance Therapeutics Inc. RVNC Russell Angus C.
Director
9,000 $12.82 10,500
(Direct)
View
2019-05-09
Option Award
2019-05-10
9:05 pm
N/A
N/A
Revance Therapeutics Inc. RVNC GARDNER PHYLLIS
Director
4,500 $0 10,500
(Direct)
View
2019-05-09
Option Award
2019-05-10
9:05 pm
N/A
2029-05-08
Revance Therapeutics Inc. RVNC GARDNER PHYLLIS
Director
9,000 $12.82 10,500
(Direct)
View
2019-05-09
Option Award
2019-05-10
8:54 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Gangolli Julian S
Director
4,500 $0 10,500
(Direct)
View
2019-05-09
Option Award
2019-05-10
8:54 pm
N/A
2029-05-08
Revance Therapeutics Inc. RVNC Gangolli Julian S
Director
9,000 $12.82 10,500
(Direct)
View
2019-05-09
Option Award
2019-05-10
8:52 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
Director
4,500 $0 20,000
(Direct)
View
2019-05-09
Option Award
2019-05-10
8:52 pm
N/A
2029-05-08
Revance Therapeutics Inc. RVNC Foley Mark J
Director
9,000 $12.82 20,000
(Direct)
View
2019-05-09
Option Award
2019-05-10
8:49 pm
N/A
N/A
Revance Therapeutics Inc. RVNC BYRNES ROBERT F
Director
4,500 $0 13,665
(Direct)
View
2019-05-09
Option Award
2019-05-10
8:49 pm
N/A
2029-05-08
Revance Therapeutics Inc. RVNC BYRNES ROBERT F
Director
9,000 $12.82 13,665
(Direct)
View
2019-03-15
Tax Withholding
2019-03-19
9:01 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Browne L Daniel
CEO
3,256 $15.45 165,687
(Direct)
View
2019-03-15
Tax Withholding
2019-03-19
9:01 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Browne L Daniel
CEO
2,881 $15.45 165,687
(Direct)
View
2019-03-15
Tax Withholding
2019-03-19
8:58 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
252 $15.45 6,898
(Direct)
View
2019-03-14
Exercise
2019-03-18
8:34 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
666 $4.2 90,443
(Direct)
View
2019-03-14
Tax Withholding
2019-03-18
8:34 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
166 $15.59 90,443
(Direct)
View
2019-03-14
Tax Withholding
2019-03-18
8:34 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
1,354 $15.45 90,443
(Direct)
View
2019-03-14
Exercise
2019-03-18
8:34 pm
N/A
2019-04-28
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
666 $4.2 90,443
(Direct)
View
2019-02-15
Tax Withholding
2019-02-20
9:33 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
1,510 $17.69 89,777
(Direct)
View
2019-02-15
Tax Withholding
2019-02-20
9:31 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Browne L Daniel
CEO
3,154 $17.69 174,389
(Direct)
View
2019-01-24
Option Award
2019-01-25
9:02 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Browne L Daniel
CEO
35,000 $0 200,000
(Direct)
View
2019-01-24
Option Award
2019-01-25
9:02 pm
N/A
2029-01-23
Revance Therapeutics Inc. RVNC Browne L Daniel
CEO
200,000 $17.23 200,000
(Direct)
View
2019-01-24
Option Award
2019-01-25
9:00 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
5,000 $0 30,000
(Direct)
View
2019-01-24
Option Award
2019-01-25
9:00 pm
N/A
2029-01-23
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
30,000 $17.23 30,000
(Direct)
View
2019-01-24
Option Award
2019-01-25
8:54 pm
N/A
N/A
Revance Therapeutics Inc. RVNC McDowell Caryn Gordon
VP
7,500 $0 50,000
(Direct)
View
2019-01-24
Option Award
2019-01-25
8:54 pm
N/A
2029-01-23
Revance Therapeutics Inc. RVNC McDowell Caryn Gordon
VP
50,000 $17.23 50,000
(Direct)
View
2019-01-24
Option Award
2019-01-25
8:51 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
3,150 $0 7,150
(Direct)
View
2019-01-24
Option Award
2019-01-25
8:51 pm
N/A
2029-01-23
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
6,500 $17.23 7,150
(Direct)
View
2019-01-24
Option Award
2019-01-25
8:49 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
15,750 $0 94,000
(Direct)
View
2019-01-24
Option Award
2019-01-25
8:49 pm
N/A
2029-01-23
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
94,000 $17.23 94,000
(Direct)
View
2019-01-22
Exercise
2019-01-23
9:38 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
625 $13.35 6,875
(Direct)
View
2019-01-22
Exercise
2019-01-23
9:38 pm
N/A
2026-10-30
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
625 $13.35 6,875
(Direct)
View
2019-01-15
Tax Withholding
2019-01-17
8:55 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
4,466 $20.19 75,537
(Direct)
View
2018-12-31
Other
2019-01-02
8:05 pm
N/A
N/A
Revance Therapeutics Inc. RVNC McDowell Caryn Gordon
VP
818 $17.11 16,818
(Direct)
View
2018-12-31
Other
2019-01-02
8:02 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
375 $17.11 4,375
(Direct)
View
2018-12-14
Tax Withholding
2018-12-14
9:23 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
4,260 $19.91 80,003
(Direct)
View
2018-11-15
Tax Withholding
2018-11-16
6:17 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
259 $20.99 4,491
(Direct)
View
2018-11-09
Exercise
2018-11-09
8:59 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
2,188 $13.35 7,500
(Direct)
View
2018-11-09
Exercise
2018-11-09
8:59 pm
N/A
2026-10-30
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Accounting Officer
2,188 $13.35 7,500
(Direct)
View
2018-11-05
Option Award
2018-11-07
8:31 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
18,000 $0 100,000
(Direct)
View
2018-11-05
Option Award
2018-11-07
8:31 pm
N/A
2028-11-04
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
100,000 $24.96 100,000
(Direct)
View
2018-10-15
Tax Withholding
2018-10-17
6:53 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Zavodnick Todd Erik
CCO & President,
7,093 $23.94 96,407
(Direct)
View
2018-06-29
Other
2018-07-03
8:20 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Financial Officer
393 $23.33 5,143
(Direct)
View
2018-06-29
Other
2018-07-03
8:17 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Browne L Daniel
CEO
668 $23.33 142,543
(Direct)
View
2018-06-20
Option Award
2018-06-22
8:58 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Financial Officer
250 $0 9,500
(Direct)
View
2018-06-20
Option Award
2018-06-22
8:58 pm
N/A
2028-06-19
Revance Therapeutics Inc. RVNC Allouche Cyril
Principal Financial Officer
9,500 $30.75 9,500
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:31 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Vickers Philip J.
Director
3,000 $0 9,150
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:31 pm
N/A
2028-05-09
Revance Therapeutics Inc. RVNC Vickers Philip J.
Director
6,000 $29.15 9,150
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:30 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Russell Angus C.
Director
3,000 $0 6,000
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:30 pm
N/A
2028-05-09
Revance Therapeutics Inc. RVNC Russell Angus C.
Director
6,000 $29.15 6,000
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:28 pm
N/A
N/A
Revance Therapeutics Inc. RVNC GARDNER PHYLLIS
Director
3,000 $0 6,000
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:28 pm
N/A
2028-05-09
Revance Therapeutics Inc. RVNC GARDNER PHYLLIS
Director
6,000 $29.15 6,000
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:27 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Gangolli Julian S
Director
3,000 $0 6,000
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:27 pm
N/A
2028-05-09
Revance Therapeutics Inc. RVNC Gangolli Julian S
Director
6,000 $29.15 6,000
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:26 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
Director
3,000 $0 20,000
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:26 pm
N/A
2028-05-09
Revance Therapeutics Inc. RVNC Foley Mark J
Director
6,000 $29.15 20,000
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:24 pm
N/A
N/A
Revance Therapeutics Inc. RVNC BYRNES ROBERT F
Director
3,000 $0 13,665
(Direct)
View
2018-05-10
Option Award
2018-05-11
8:24 pm
N/A
2028-05-09
Revance Therapeutics Inc. RVNC BYRNES ROBERT F
Director
6,000 $29.15 13,665
(Direct)
View
2018-05-01
Option Award
2018-05-03
8:23 pm
N/A
N/A
Revance Therapeutics Inc. RVNC McDowell Caryn Gordon
VP
16,000 $0 110,000
(Direct)
View
2018-05-01
Option Award
2018-05-03
8:23 pm
N/A
2028-04-30
Revance Therapeutics Inc. RVNC McDowell Caryn Gordon
VP
110,000 $28.3 110,000
(Direct)
View
2018-03-21
Exercise
2018-03-23
9:13 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
666 $2.55 84,263
(Direct)
View
2018-03-21
Exercise
2018-03-23
9:13 pm
N/A
2018-04-29
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
666 $2.55 84,263
(Direct)
View
Goto page 0, 1, Next